Loading...

Abcam plc

ABCMNASDAQ
Healthcare
Biotechnology
$23.99
$0.010(0.04%)

Abcam plc (ABCM) Stock Competitors & Peer Comparison

See (ABCM) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ABCM$23.99+0.04%5.5B2399.00$0.01N/A
VRTX$395.12-0.59%101.2B28.05$14.07N/A
REGN$589.48-1.45%61.4B14.86$39.66+0.45%
ALNY$454.38-2.82%59.6B-184.02-$2.47N/A
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ARGX$660.00-0.56%40.4B33.59$19.65N/A
BNTX$110.88+0.10%26.7B-66.80-$1.66N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
SMMT$26.20+0.73%19.5B-25.94-$1.01N/A
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ABCM vs VRTX Comparison August 2025

ABCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ABCM stands at 5.5B. In comparison, VRTX has a market cap of 101.2B. Regarding current trading prices, ABCM is priced at $23.99, while VRTX trades at $395.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ABCM currently has a P/E ratio of 2399.00, whereas VRTX's P/E ratio is 28.05. In terms of profitability, ABCM's ROE is -0.01%, compared to VRTX's ROE of +0.22%. Regarding short-term risk, ABCM is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for ABCM.Check VRTX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;